Rumey C. Ishizawar, MD, PhD

EMAIL: rumey_ishizawar@med.unc.edu

PERSONAL WEBSITE: https://www.med.unc.edu/medicine/rheumatology-allergy-immunology/directory/rumey-c-ishizawar-md-phd/

PUBLICATIONS: Publications Link

Rumey Ishizawar, MD, PhD, is a general rheumatologist seeing all rheumatic conditions. She has been involved in prior research focused on cancer cell signaling pathways and functional genomic research in rheumatoid arthritis. Dr. Ishizawar’s current research interest is understanding mechanisms leading to immune related adverse events (irAEs) from immune checkpoint inhibitors (ICIs) used to treat patients with cancer. Dr. Ishizawar is the lead for the UNC Immuno-Oncology Group (IOG) and is building an infrastructure to understand and address irAE through a prospective longitudinal bioregistry to support clinical, translational and basic science research. Dr. Ishizawar is also engaged in collaborative retrospective chart review studies to understand irAEs. In addition to her clinical and research efforts, Dr. Ishizawar is involved in medical education at UNC-Chapel Hill as well as through the American College of Rheumatology. Dr. Ishizawar is the Program Director for the UNC Adult Rheumatology Fellowship Training Program, a member of the UNC School of Medicine Academy of Educators and serves as a Section Chief for the ACR Continuing, Assessment, and Review (CARE) module, an online self assessment and educational tool.